WPI 2232 (Tamoxifen 10 mg)
Pill imprint WPI 2232 has been identified as Tamoxifen citrate 10 mg.
Tamoxifen is used in the treatment of breast cancer, adjuvant; breast cancer, metastatic; breast cancer; breast cancer, palliative; breast cancer, male (and more), and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 10 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WPI 2232 (Tamoxifen 10 mg)
- Imprint:
-
WPI
2232 - Strength:
- 10 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Hormones/antineoplastics
Selective estrogen receptor modulators - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals, Inc.
More resources
Tamoxifen citrate is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
